Originally published on Fri August 24, 2012 1:19 pm
A PET scan of the brain of a person with Alzheimer's disease.
Credit U.S. National Institute on Aging / Wikimedia Commons
An experimental drug that aimed to slow the development of plaques and help clear them from the brains of Alzheimer's patients failed in two late-stage studies conducted by Eli Lilly & Co., the company said today.
There's ample evidence cholesterol-lowering pills called statins can reduce the risk of a repeat heart attack. The pills are frequently prescribed for people who've never had a heart attack or stroke, but are at high risk for trouble.
The pharmacy at Atlanta's Ponce de Leon Center stocks medications for 5,200 HIV/AIDS patients. Workers there aren't sure how much an increase in federal aid will help cut Georgia's waiting list for a HIV drug-assistance program.
Credit Jim Burress / WABE, Atlanta
The Obama administration last week announced nearly $80 million in grants to increase access to AIDS care across the United States. But will the money be enough to eliminate waiting lists for the AIDS Drug Assistance Program?
Advocates aren't sure. The program, known as ADAP, provides a safety net for people with HIV who have no means of paying for the drugs they need to fight the virus.